Surgery Partners logo

Surgery Partners

SGRY | NASDAQ
Chart Builder DCF Calculator
$26.79
-$0.16 (-0.59%)
At close: Nov 16, 2026, 4:00 PM ET
$26.82
+$0.03 (+0.11%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.59%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
39.6
Fundamentals Weak
Market Sentiment Bullish
Moat Narrow
Sector Rank #536/1021 (Top 52%)

Key Statistics

Market Data

Market Cap $3.51B
1D Range
26.62 26.95
52W Range
11.49 26.95

Valuation (TTM)

PE -39.99
PB 2.11
EV/EBITDA 9.69

Valuation (NTM)

Forward PE 76.97
Forward PEG 0.89
Price Target $23.50
Loading financial charts...

Profile

Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility S...

Sector Healthcare
Employees 16,000
IPO Date Sep 30, 2015
Fiscal Year January - December

Latest News

SGRY Securities Notice: Surgery Partners Shareholders are Notified to Contact BFA Law about its Investigation into the $23.50 per Share Take-Private Merger

5 days ago · globenewswire.com

SGRY Securities Notice: Surgery Partners Shareholders are Notified to Contact BFA Law about its Investigation into the $23.50 per Share Take-Private Merger
Surgery Partners (SGRY) Beats Q3 Earnings Estimates

7 days ago · zacks.com

Surgery Partners (SGRY) Beats Q3 Earnings Estimates
SGRY Deal Alert: Surgery Partners $23.50 per Share Merger Under Investigation – Contact BFA Law about the Pending Merger Investigation

8 days ago · globenewswire.com

SGRY Deal Alert: Surgery Partners $23.50 per Share Merger Under Investigation – Contact BFA Law about the Pending Merger Investigation
SGRY Investigation Reminder: Surgery Partners Shareholders Notified of Investigation into $23.50 per Share Merger – Contact BFA Law

11 days ago · globenewswire.com

SGRY Investigation Reminder: Surgery Partners Shareholders Notified of Investigation into $23.50 per Share Merger – Contact BFA Law
SGRY Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Surgery Partners to HealthSpan Partners

13 days ago · globenewswire.com

SGRY Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Surgery Partners to HealthSpan Partners
SGRY Investigation Reminder: Surgery Partners $23.50 per Share Merger Triggers Investigation on Behalf of Shareholders – Contact BFA Law if You Hold Shares

13 days ago · globenewswire.com

SGRY Investigation Reminder: Surgery Partners $23.50 per Share Merger Triggers Investigation on Behalf of Shareholders – Contact BFA Law if You Hold Shares
SGRY Shareholder Notice: Surgery Partners $23.50 per Share Merger Under Investigation on Behalf of Shareholders

14 days ago · prnewswire.com

SGRY Shareholder Notice: Surgery Partners $23.50 per Share Merger Under Investigation on Behalf of Shareholders
SGRY Legal Notice: Surgery Partners Shareholders Are Notified to Contact BFA Law About the Ongoing Investigation Into the $23.50 Per Share Merger

15 days ago · businesswire.com

SGRY Legal Notice: Surgery Partners Shareholders Are Notified to Contact BFA Law About the Ongoing Investigation Into the $23.50 Per Share Merger
SGRY Investigation Reminder: Surgery Partners' $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares

18 days ago · globenewswire.com

SGRY Investigation Reminder: Surgery Partners' $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares
SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share Merger

19 days ago · newsfilecorp.com

SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share Merger

Earnings

Latest Earnings
Nov 9, 2026
EPS
$0.16
Beat +44.67%
REV
$815.3M
Miss -0.69%
Next Earnings
Mar 1, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Hold
Price Target
$23.50
Downside
-12.28%
Buy (2)
Hold (6)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.